How to buy Singular Genomics Systems IncCommon Stock stock | $14.02

Singular Genomics Systems Inc. Common Stock is a medical instruments & supplies business based in the US. Singular Genomics Systems IncCommon Stock shares (OMIC) are listed on the NASDAQ and all prices are listed in US Dollars. Singular Genomics Systems IncCommon Stock employs 169 staff and has a market cap (total outstanding shares value) of 0.00.

Singular Genomics Systems IncCommon Stock stock price (NASDAQ: OMIC)

Use our graph to track the performance of OMIC stocks over time.

Singular Genomics Systems IncCommon Stock shares at a glance

• Key figures

Information last updated 2021-10-10.

Latest market close	$14.02
52-week range	$10.80 - $33.37
50-day moving average	$14.29
200-day moving average	$19.01
Wall St. target price	$30.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-4.76

Buy Singular Genomics Systems IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Singular Genomics Systems IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Singular Genomics Systems IncCommon Stock price performance over time

Historical closes compared with the close of $14.02 from 2021-10-15

1 week (2021-10-08)	14.26%
1 month (2021-09-16)	0.79%
3 months (2021-07-16)	-25.86%
6 months (2021-04-12)	N/A

1 year (2020-10-12)	N/A
2 years (2019-10-12)	N/A
3 years (2018-10-12)	N/A
5 years (2016-10-12)	N/A

Singular Genomics Systems IncCommon Stock financials

Gross profit TTM	$0
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	$5.13
Market capitalisation	$878 million

TTM: trailing 12 months

Shorting Singular Genomics Systems IncCommon Stock shares

There are currently 684,937 Singular Genomics Systems IncCommon Stock shares held short by investors – that's known as Singular Genomics Systems IncCommon Stock's "short interest". This figure is 2.9% up from 665,333 last month.

There are a few different ways that this level of interest in shorting Singular Genomics Systems IncCommon Stock shares can be evaluated.

Singular Genomics Systems IncCommon Stock's "short interest ratio" (SIR)

Singular Genomics Systems IncCommon Stock's "short interest ratio" (SIR) is the quantity of Singular Genomics Systems IncCommon Stock shares currently shorted divided by the average quantity of Singular Genomics Systems IncCommon Stock shares traded daily (recently around 130216.15969582). Singular Genomics Systems IncCommon Stock's SIR currently stands at 5.26. In other words for every 100,000 Singular Genomics Systems IncCommon Stock shares traded daily on the market, roughly 5260 shares are currently held short.

To gain some more context, you can compare Singular Genomics Systems IncCommon Stock's short interest ratio against those of similar companies.

• Illumina (ILMN.US): 2.46
• CRISPR Therapeutics (CRSP.US): 2.86
• Bionano Genomics (BNGO.US): 6.14

However Singular Genomics Systems IncCommon Stock's short interest can also be evaluated against the total number of Singular Genomics Systems IncCommon Stock shares, or, against the total number of tradable Singular Genomics Systems IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Singular Genomics Systems IncCommon Stock's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Singular Genomics Systems IncCommon Stock shares in existence, roughly 10 shares are currently held short) or 0.0213% of the tradable shares (for every 100,000 tradable Singular Genomics Systems IncCommon Stock shares, roughly 21 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Singular Genomics Systems IncCommon Stock.

Find out more about how you can short Singular Genomics Systems IncCommon Stock stock.

Singular Genomics Systems IncCommon Stock share dividends

We're not expecting Singular Genomics Systems IncCommon Stock to pay a dividend over the next 12 months.

Singular Genomics Systems IncCommon Stock overview

Singular Genomics Systems, Inc. , a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California. .

Frequently asked questions

What percentage of Singular Genomics Systems IncCommon Stock is owned by insiders or institutions?
Currently 21.103% of Singular Genomics Systems IncCommon Stock shares are held by insiders and 63.498% by institutions. How many people work for Singular Genomics Systems IncCommon Stock?
Latest data suggests 169 work at Singular Genomics Systems IncCommon Stock. When does the fiscal year end for Singular Genomics Systems IncCommon Stock?
Singular Genomics Systems IncCommon Stock's fiscal year ends in December. Where is Singular Genomics Systems IncCommon Stock based?
Singular Genomics Systems IncCommon Stock's address is: 10931 North Torrey Pines Road, LA Jolla, CA, United States, 92037 What is Singular Genomics Systems IncCommon Stock's ISIN number?
Singular Genomics Systems IncCommon Stock's international securities identification number is: US82933R1005